Scinovex
articleTop 1% cited

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

European Heart Journal · 2012 · Vol. 33(21) · pp. 2719–2747

Abstract

Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsHealth Systems, Economic Evaluations, Quality of LifeMedicineAtrial fibrillationManagement of atrial fibrillationIntensive care medicineCardiology

MeSH terms

Anti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationElectric CountershockHeart FailureHemorrhageHumansThromboembolismCatheter AblationRisk AssessmentAtrial AppendageStrokeEarly DiagnosisTherapeutic Occlusion
Citations
2,889
FWCI
238.33
field-weighted impact
References
203
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.